Profilo
Snehal Shah currently works at Oculis Holding AG, as President-Research & Development from 2024.
Dr. Shah also formerly worked at Noven Pharmaceuticals, Inc., as Member-Hisamitsu Group from 2012 to 2017, Kyowa Kirin Co., Ltd., as Senior Vice President-Regulatory Affairs from 2017 to 2021, and IVERIC bio, Inc., as SVP, Chief Regulatory & Product Strategy Officer.
Dr. Shah received his doctorate degree from the University of Kansas and undergraduate degree from Rutgers University- Newark.
Posizioni attive di Snehal Shah
| Società | Posizione | Inizio |
|---|---|---|
| OCULIS HOLDING AG | Direttore Tecnico/Scientifico/R&S | 10/04/2024 |
Precedenti posizioni note di Snehal Shah
| Società | Posizione | Fine |
|---|---|---|
| KYOWA KIRIN CO., LTD. | Consigliere Generale | 01/01/2021 |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Corporate Officer/Principal | 01/01/2017 |
| IVERIC BIO, INC. | Consigliere Generale | - |
Formazione di Snehal Shah
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Commercial Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Rutgers University- Newark
Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oculis Holding AG
Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
















